BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 20385723)

  • 21. Clinical, Biological, Radiological Pathological and Immediate Post-Operative Remission of Sparsely and Densely Granulated Corticotroph Pituitary Tumors: A Retrospective Study of a Cohort of 277 Patients With Cushing's Disease.
    Rak B; Maksymowicz M; Pękul M; Zieliński G
    Front Endocrinol (Lausanne); 2021; 12():672178. PubMed ID: 34135861
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Early post-operative ACTH and cortisol as predictors of remission in Cushing's disease.
    Acebes JJ; Martino J; Masuet C; Montanya E; Soler J
    Acta Neurochir (Wien); 2007; 149(5):471-7; discussion 477-9. PubMed ID: 17406780
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Low level of glucocorticoid receptor messenger ribonucleic acid in pituitary adenomas manifesting Cushing's disease with resistance to a high dose-dexamethasone suppression test.
    Mu YM; Takayanagi R; Imasaki K; Ohe K; Ikuyama S; Yanase T; Nawata H
    Clin Endocrinol (Oxf); 1998 Sep; 49(3):301-6. PubMed ID: 9861319
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MGMT expression in pituitary corticotroph adenomas and its relationship to clinical, pathological, and ultrastructural parameters in patients with Cushing's disease.
    Witek P; Maksymowicz M; Szamotulska K; Piaścik A; Wojciechowska-Luźniak A; Stasiewicz A; Witek J; Zieliński G
    Folia Neuropathol; 2020; 58(4):357-364. PubMed ID: 33480240
    [TBL] [Abstract][Full Text] [Related]  

  • 25. ACTH-secreting pituitary adenomas: size does not correlate with hormonal activity.
    Mathioudakis N; Pendleton C; Quinones-Hinojosa A; Wand GS; Salvatori R
    Pituitary; 2012 Dec; 15(4):526-32. PubMed ID: 22057967
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Role of Glucocorticoid Receptor in the Pathophysiology of Pituitary Corticotroph Adenomas.
    Regazzo D; Mondin A; Scaroni C; Occhi G; Barbot M
    Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35742910
    [TBL] [Abstract][Full Text] [Related]  

  • 27. FSH-producing macroadenoma associated in a patient with Cushing's disease.
    Oyama K; Yamada S; Hukuhara N; Hiramatsu R; Taguchi M; Yazawa M; Matsuda A; Ohmura E; Imai Y
    Neuro Endocrinol Lett; 2006 Dec; 27(6):733-6. PubMed ID: 17187002
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Of old and new diseases: genetics of pituitary ACTH excess (Cushing) and deficiency.
    Drouin J; Bilodeau S; Vallette S
    Clin Genet; 2007 Sep; 72(3):175-82. PubMed ID: 17718852
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Corticotropin-releasing hormone, proopiomelanocortin, and glucocorticoid receptor gene expression in adrenocorticotropin-producing tumors in vitro.
    Suda T; Tozawa F; Dobashi I; Horiba N; Ohmori N; Yamakado M; Yamada M; Demura H
    J Clin Invest; 1993 Dec; 92(6):2790-5. PubMed ID: 8254033
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Silent corticotroph adenomas: Emory University cohort and comparison with ACTH-negative nonfunctioning pituitary adenomas.
    Ioachimescu AG; Eiland L; Chhabra VS; Mastrogianakis GM; Schniederjan MJ; Brat D; Pileggi AV; Oyesiku NM
    Neurosurgery; 2012 Aug; 71(2):296-303; discussion 304. PubMed ID: 22517250
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Corticotroph tumor progression after adrenalectomy in Cushing's Disease: A reappraisal of Nelson's Syndrome.
    Assié G; Bahurel H; Coste J; Silvera S; Kujas M; Dugué MA; Karray F; Dousset B; Bertherat J; Legmann P; Bertagna X
    J Clin Endocrinol Metab; 2007 Jan; 92(1):172-9. PubMed ID: 17062771
    [TBL] [Abstract][Full Text] [Related]  

  • 32. ACTH and alpha-subunit are co-expressed in rare human pituitary corticotroph cell adenomas proposed to originate from ACTH-committed early pituitary progenitor cells.
    Suzuki M; Egashira N; Kajiya H; Minematsu T; Takekoshi S; Tahara S; Sanno N; Teramoto A; Osamura RY
    Endocr Pathol; 2008; 19(1):17-26. PubMed ID: 18228160
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differential regulation of proopiomelanocortin and pituitary-restricted transcription factor (TPIT), a new marker of normal and adenomatous human corticotrophs.
    Vallette-Kasic S; Figarella-Branger D; Grino M; Pulichino AM; Dufour H; Grisoli F; Enjalbert A; Drouin J; Brue T
    J Clin Endocrinol Metab; 2003 Jul; 88(7):3050-6. PubMed ID: 12843142
    [TBL] [Abstract][Full Text] [Related]  

  • 34. EGFR as a therapeutic target for human, canine, and mouse ACTH-secreting pituitary adenomas.
    Fukuoka H; Cooper O; Ben-Shlomo A; Mamelak A; Ren SG; Bruyette D; Melmed S
    J Clin Invest; 2011 Dec; 121(12):4712-21. PubMed ID: 22105169
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of protracted treatment with rosiglitazone, a PPARgamma agonist, in patients with Cushing's disease.
    Pecori Giraldi F; Scaroni C; Arvat E; Martin M; Giordano R; Albiger N; Leao AA; Picu A; Mantero F; Cavagnini F
    Clin Endocrinol (Oxf); 2006 Feb; 64(2):219-24. PubMed ID: 16430724
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pro-opiomelanocortin gene expression in silent corticotroph-cell adenoma and Cushing's disease.
    Nagaya T; Seo H; Kuwayama A; Sakurai T; Tsukamoto N; Nakane T; Sugita K; Matsui N
    J Neurosurg; 1990 Feb; 72(2):262-7. PubMed ID: 2153197
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multihormonal pituitary adenoma concomitant with Pit-1 and Tpit lineage cells causing acromegaly associated with subclinical Cushing's disease: a case report.
    Takiguchi T; Koide H; Nagano H; Nakayama A; Fujimoto M; Tamura A; Komai E; Shiga A; Kono T; Higuchi S; Sakuma I; Hashimoto N; Suzuki S; Miyabayashi Y; Ishiwatari N; Horiguchi K; Nakatani Y; Yokote K; Tanaka T
    BMC Endocr Disord; 2017 Sep; 17(1):54. PubMed ID: 28865461
    [TBL] [Abstract][Full Text] [Related]  

  • 38. No mutations in TPIT, a corticotroph-specific gene, in human tumoral pituitary ACTH-secreting cells.
    Bucciarelli LG; Pecori Giraldi F; Cavagnini F
    J Endocrinol Invest; 2005 Dec; 28(11):1015-8. PubMed ID: 16483181
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reversible "brain atrophy" in patients with Cushing's disease.
    Gnjidić Z; Sajko T; Kudelić N; Malenica M; Vizner B; Vrkljan M; Hat J; Rumboldt Z
    Coll Antropol; 2008 Dec; 32(4):1165-70. PubMed ID: 19149224
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Digital analysis of hormonal immunostaining in pituitary adenomas classified according to WHO 2017 criteria and correlation with preoperative laboratory findings.
    Tamanini JVG; Dal Fabbro M; de Freitas LLL; Vassallo J; de Souza Queiroz L; Rogerio F
    Neurosurg Focus; 2020 Jun; 48(6):E12. PubMed ID: 32480373
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.